Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) Operating Expenses (2016 - 2025)

Aethlon Medical filings provide 15 years of Operating Expenses readings, the most recent being $2.0 million for Q1 2025.

  • On a quarterly basis, Operating Expenses fell 19.39% to $2.0 million in Q1 2025 year-over-year; TTM through Mar 2025 was $9.3 million, a 26.07% decrease, with the full-year FY2025 number at $9.3 million, down 26.08% from a year prior.
  • Operating Expenses hit $2.0 million in Q1 2025 for Aethlon Medical, up from $1.8 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $3.8 million in Q1 2022 to a low of $1.8 million in Q4 2024.
  • Median Operating Expenses over the past 5 years was $2.8 million (2022), compared with a mean of $2.8 million.
  • Biggest five-year swings in Operating Expenses: skyrocketed 71.21% in 2022 and later plummeted 49.13% in 2024.
  • Aethlon Medical's Operating Expenses stood at $2.5 million in 2021, then rose by 11.97% to $2.8 million in 2022, then increased by 25.17% to $3.6 million in 2023, then plummeted by 49.13% to $1.8 million in 2024, then grew by 10.43% to $2.0 million in 2025.
  • The last three reported values for Operating Expenses were $2.0 million (Q1 2025), $1.8 million (Q4 2024), and $2.9 million (Q3 2024) per Business Quant data.